00000000cam 2200000zi 4500
0019.962284
003CaOODSP
00520260605141338
006m     o  d f      
007cr cn|||||||||
008260428e202605##onca    ob   f000 0 eng d
020 |a9780660997438 |q(statement)
020 |a9780660997445 |q(summary)
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-403/2026E-PDF
0861 |aHP40-403/2026-1E-PDF
24500|aNACI rapid response : |bupdate on the use of quadrivalent conjugate meningococcal vaccines in children under 2 years of age.
24617|aUpdate on the use of quadrivalent conjugate meningococcal vaccines in children under 2 years of age
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cMay 2026.
264 4|c©2026
300 |a1 online resource (51 pages) : |bcolour illustrations + |esummary (4 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Réponse rapide du CCNI : mise à jour sur l'utilisation des vaccins conjugués quadrivalents contre le méningocoque chez les enfants de moins de 2 ans.
500 |aTitle from cover.
500 |a"An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI)."
500 |a"Pub.: 260053"--Page 2 (statement).
500 |a"Pub.: 260051"--Page 2 (summary).
504 |aIncludes bibliographical references (pages 20-25).
650 6|aMeningococcal infections|xVaccination|xGovernment policy|zCanada.
650 6|aVaccination of infants|xGovernment policy|zCanada.
650 6|aBacterial vaccines|xGovernment policy|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
7101 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body.
77508|tRéponse rapide du CCNI : |w(CaOODSP)9.962283
85640|qPDF|s899 KB|uhttps://publications.gc.ca/collections/collection_2026/aspc-phac/HP40-403-2026-eng.pdf|zStatement
85640|qPDF|s243 KB|uhttps://publications.gc.ca/collections/collection_2026/aspc-phac/HP40-403-2026-1-eng.pdf|zSummary
986 |a260053
986 |a260051